Literature DB >> 8499995

Prediction of recovery in antenatally diagnosed hydronephrosis.

K J O'Flynn1, D C Gough, S Gupta, M A Lewis, R J Postlethwaite.   

Abstract

A series of 335 children with antenatally diagnosed hydronephrosis which persisted after the postnatal period was prospectively assessed. Idiopathic hydronephrosis (85 patients) and pelviureteric junction obstruction (73 patients) were the commonest conditions. All patients with idiopathic hydronephrosis were managed conservatively; 87% have had a complete resolution of hydronephrosis and 13% have remained unaltered. No patient managed conservatively has shown a deterioration in renal function.

Entities:  

Mesh:

Year:  1993        PMID: 8499995     DOI: 10.1111/j.1464-410x.1993.tb15997.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  5 in total

Review 1.  Postnatal management of hydronephrosis diagnosed in utero.

Authors:  J Radhakrishnan; G Lievano
Journal:  Indian J Pediatr       Date:  1997 May-Jun       Impact factor: 1.967

Review 2.  Outcome of isolated antenatal hydronephrosis: a systematic review and meta-analysis.

Authors:  Gagan Sidhu; Joseph Beyene; Norman D Rosenblum
Journal:  Pediatr Nephrol       Date:  2005-12-17       Impact factor: 3.714

3.  Urinary proteome analysis identifies infants but not older children requiring pyeloplasty.

Authors:  Jens Drube; Petra Zürbig; Eric Schiffer; Esther Lau; Benno Ure; Sylvia Glüer; Martin Kirschstein; Lars Pape; Stéphane Decramer; Jean-Loup Bascands; Joost P Schanstra; Harald Mischak; Jochen H H Ehrich
Journal:  Pediatr Nephrol       Date:  2010-02-24       Impact factor: 3.714

Review 4.  [Urinary proteomics: the diagnostic key for urinary tract abnormalities and kidney diseases in children?].

Authors:  J H H Ehrich; E Schiffer; J Drube
Journal:  Urologe A       Date:  2011-02       Impact factor: 0.639

5.  Postnatal management of infants with antenatally detected hydronephrosis.

Authors:  Nejat Aksu; Onder Yavaşcan; Murat Kangin; Orhan D Kara; Yahya Aydin; Hakan Erdoğan; Tuba Cerçi Tuncel; Ergün Cetinkaya; Erkan Ozbay; Tahir G Sandikçioğlu
Journal:  Pediatr Nephrol       Date:  2005-07-16       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.